万维书刊网微信二维码

扫微信,关注编辑QQ!

您的位置:万维书刊网 >>sci/e期刊大全 >>医药卫生1>>外科

SURGICAL INNOVATION《外科创新》 (官网投稿)

简介
  • 期刊简称SURG INNOV
  • 参考译名《外科创新》
  • 核心类别 SCIE(2024版), 目次收录(维普),外文期刊,
  • IF影响因子
  • 自引率7.10%
  • 主要研究方向医学-SURGERY 外科

主要研究方向:

等待设置主要研究方向
医学-SURGERY 外科

SURGICAL INNOVATION《外科创新》(双月刊). Surgical Innovation: Advances in Minimally Invasive Surgical Science, Technology, and Training focuses on the&nbs...[显示全部]
征稿信息

万维提示:

1、投稿方式:在线投稿。

2、期刊网址:http://journals.sagepub.com/home/sri

3、投稿网址:https://mc.manuscriptcentral.com/sri

4、官网邮箱:lswanstrom@gmail.com

5、期刊刊期:双月刊,逢双月出版。

2021531日星期一

                             

 

投稿须知【官网信息】

 

Manuscript Submission Guidelines:

This Journal is a member of the Committee on Publication Ethics.

This Journal recommends that authors follow the Recommendations for the Conduct, Reporting, Editing, and Publication of Scholarly Work in Medical Journals formulated by the International Committee of Medical Journal Editors (ICMJE).

Please read the guidelines below then visit Surgical Innovation (SRI)’s submission site to upload your manuscript. Please note that manuscripts not conforming to these guidelines may be returned. Remember you can log in to the submission site at any time to check on the progress of your paper through the peer review process.

SAGE Publishing disseminates high-quality research and engaged scholarship globally, and we are committed to diversity and inclusion in publishing. We encourage submissions from a diverse range of authors from across all countries and backgrounds.

Only manuscripts of sufficient quality that meet the aims and scope of SRI will be reviewed.

Thee are no fees payable to submit or publish in this journal.

As part of the submission process you will be required to warrant that you are submitting your original work, that you have the rights in the work, and that you have obtained and can supply all necessary permissions for the reproduction of any copyright works not owned by you, that you are submitting the work for first publication in the Journal and that it is not being considered for publication elsewhere and has not already been published elsewhere. Please see our guidelines on prior publication and note that SRI may accept submissions of papers that have been posted on pre-print servers; please alert the Editorial Office when submitting (contact details are at the end of these guidelines) and include the DOI for the preprint in the designated field in the manuscript submission system. Authors should not post an updated version of their paper on the preprint server while it is being peer reviewed for possible publication in the journal. If the article is accepted for publication, the author may re-use their work according to the journal's author archiving policy. If your paper is accepted, you must include a link on your preprint to the final version of your paper.

If you have any questions about publishing with SAGE, please visit the SAGE Journal Solutions Portal.

1. What do we publish?

1.1 Aims & Scope

Surgical Innovation: Advances in Minimally Invasive Surgical Science, Technology, and Training is dedicated to becoming the core reference for the most advanced aspects of innovative surgical practice for the most innovative surgeons. It focuses on the revolution that minimally invasive surgical techniques, new instruments such as laparoscopes, endoscopes and robots and new technologies like AI, virtual reality and personalized medicine have brought to the art, science, and business of surgery. Each issue of SRI offers unique and peer-reviewed articles from the vanguard of clinical practice: noteworthy and innovative research from the basic sciences, state-of-the-art surgical education, and useful insights into the business and practice of surgery. The journal gives you perceptive and incisive articles that highlight those practices and technologies that will change your practice today and revolutionize surgery for decades to come.

1.2 Article types

Acceptable categories for submission include:

Editorials: should be brief and to the point, less than 700 words and be cleared by the editors before submission. They have no abstract or key words and less than 10 references.

Inventor's Corner: innovative solutions to surgical problems that have preliminary proof of concept but are not commercially available yet. They should be a maximum of 800 words, have a maximum of 3 images and maximum of 8 references.

Letters to the Editor: letters should be addressed to the editors and can either address a published paper or a surgical opinion. They have no abstract or key words and do not use a structured format. They should be 600 words or less, have a maximum of 5 references and 1 table or figure. References are not included in the word count.

Original Papers: submissions should be less than 5,000 words and be formatted with an abstract, key words and a structured format (background, method, statistics, results, discussion and conclusion). Tables and references are not included in the word count. All should include relevant ethical approvals, acknowledgements and conflict of interest statements. Lists of authors in excess of 8 are discouraged and only authors truly involved in the work should be cited. Papers that exceed 8 authors require a note of explanation for each author's contribution to the research.

They should be assigned to the following categories:

History of Innovation

In Context: Review

Innovative Technologies

View from IRCAD

Procedural Innovations

Original Clinical Science

Surgical Education: Training for the Future

Business in Innovation

Frugal Innovation

Global Surgery

Case studies are not routinely accepted in SRI and should only be submitted if they represent an absolutely novel or breakthrough technology or technique.

1.3 Writing your paper

The SAGE Author Gateway has some general advice on how to get published, plus links to further resources.

1.3.1 Make your article discoverable

For information and guidance on how to make your article more discoverable, visit our Gateway page on How to Help Readers Find Your Article Online

2. Editorial policies

2.1 Peer review policy

SRI operates a conventional single-blind reviewing policy in which the reviewer’s name is always concealed from the submitting author.

As part of the submission process you will be asked to provide the names of two peers who could be called upon to review your manuscript. Recommended reviewers should be experts in their fields and should be able to provide an objective assessment of the manuscript. Please be aware of any conflicts of interest when recommending reviewers. Examples of conflicts of interest include (but are not limited to) the below:

The reviewer should have no prior knowledge of your submission

The reviewer should not have recently collaborated with any of the authors

Reviewer nominees from the same institution as any of the authors are not permitted

You will also be asked to nominate peers who you do not wish to review your manuscript (opposed reviewers).

Please note that the Editors are not obliged to invite/reject any recommended/opposed reviewers to assess your manuscript.

SRI is committed to delivering high quality, fast peer-review for your paper, and as such has partnered with Publons. Publons is a third party service that seeks to track, verify and give credit for peer review. Reviewers for the journal can opt in to Publons in order to claim their reviews or have them automatically verified and added to their reviewer profile. Reviewers claiming credit for their review will be associated with the relevant journal, but the article name, reviewer’s decision and the content of their review is not published on the site. For more information visit the Publons website.

The Editor or members of the Editorial Board may occasionally submit their own manuscripts for possible publication in the journal. In these cases, the peer review process will be managed by alternative members of the Board and the submitting Editor/Board member will have no involvement in the decision-making process.

2.2 Authorship

Papers should only be submitted for consideration once consent is given by all contributing authors. Those submitting papers should carefully check that all those whose work contributed to the paper are acknowledged as contributing authors.

The list of authors should include all those who can legitimately claim authorship. This is all those who:

Made a substantial contribution to the concept or design of the work; or acquisition, analysis or interpretation of data,

Drafted the article or revised it critically for important intellectual content,

Approved the version to be published,

Each author should have participated sufficiently in the work to take public responsibility for appropriate portions of the content.

Authors should meet the conditions of all of the points above. When a large, multicentre group has conducted the work, the group should identify the individuals who accept direct responsibility for the manuscript. These individuals should fully meet the criteria for authorship.

Acquisition of funding, collection of data, or general supervision of the research group alone does not constitute authorship, although all contributors who do not meet the criteria for authorship should be listed in the Acknowledgments section. Please refer to the International Committee of Medical Journal Editors (ICMJE) authorship guidelines for more information on authorship.

2.3 Acknowledgements

All contributors who do not meet the criteria for authorship should be listed in an Acknowledgements section. Examples of those who might be acknowledged include a person who provided purely technical help, or a department chair who provided only general support.

[FOR SINGLE BLIND JOURNALS: Any acknowledgements should appear first at the end of your article prior to your Declaration of Conflicting Interests (if applicable), any notes and your References.]

[FOR DOUBLE BLIND JOURNALS: Please supply any personal acknowledgements separately to the main text to facilitate anonymous peer review.]

2.3.1 Third party submissions

Where an individual who is not listed as an author submits a manuscript on behalf of the author(s), a statement must be included in the Acknowledgements section of the manuscript and in the accompanying cover letter. The statements must:

Disclose this type of editorial assistance – including the individual’s name, company and level of input

Identify any entities that paid for this assistance

Confirm that the listed authors have authorized the submission of their manuscript via third party and approved any statements or declarations, e.g. conflicting interests, funding, etc.

Where appropriate, SAGE reserves the right to deny consideration to manuscripts submitted by a third party rather than by the authors themselves.

2.3.2 Writing assistance

Individuals who provided writing assistance, e.g. from a specialist communications company, do not qualify as authors and so should be included in the Acknowledgements section. Authors must disclose any writing assistance – including the individual’s name, company and level of input – and identify the entity that paid for this assistance. It is not necessary to disclose use of language polishing services.

2.4 Funding

SRI requires all authors to acknowledge their funding in a consistent fashion under a separate heading.  Please visit the Funding Acknowledgements page on the SAGE Journal Author Gateway to confirm the format of the acknowledgment text in the event of funding, or state that: This research received no specific grant from any funding agency in the public, commercial, or not-for-profit sectors.

2.5 Declaration of conflicting interests

It is the policy of SRI to require a declaration of conflicting interests from all authors enabling a statement to be carried within the paginated pages of all published articles.

Please ensure that a ‘Declaration of Conflicting Interests’ statement is included at the end of your manuscript, after any acknowledgements and prior to the references. If no conflict exists, please state that ‘The Author(s) declare(s) that there is no conflict of interest’. For guidance on conflict of interest statements, please see the ICMJE recommendations here

2.6 Research ethics and patient consent

Medical research involving human subjects must be conducted according to the World Medical Association Declaration of Helsinki

Submitted manuscripts should conform to the ICMJE Recommendations for the Conduct, Reporting, Editing, and Publication of Scholarly Work in Medical Journals, and all papers reporting animal and/or human studies must state in the methods section that the relevant Ethics Committee or Institutional Review Board provided (or waived) approval. Please ensure that you have provided the full name and institution of the review committee, in addition to the approval number.

For research articles, authors are also required to state in the methods section whether participants provided informed consent and whether the consent was written or verbal.

Information on informed consent to report individual cases or case series should be included in the manuscript text. A statement is required regarding whether written informed consent for patient information and images to be published was provided by the patient(s) or a legally authorized representative. Please do not submit the patient’s actual written informed consent with your article, as this in itself breaches the patient’s confidentiality. The Journal requests that you confirm to us, in writing, that you have obtained written informed consent but the written consent itself should be held by the authors/investigators themselves, for example in a patient’s hospital record. The confirmatory letter may be uploaded with your submission as a separate file.

Please also refer to the ICMJE Recommendations for the Protection of Research Participants

All research involving animals submitted for publication must be approved by an ethics committee with oversight of the facility in which the studies were conducted. The journal has adopted the Consensus Author Guidelines on Animal Ethics and Welfare for Veterinary Journals published by the International Association of Veterinary Editors.

2.7 Clinical trials

SRI conforms to the ICMJE requirement that clinical trials are registered in a WHO-approved public trials registry at or before the time of first patient enrolment as a condition of consideration for publication. The trial registry name and URL, and registration number must be included at the end of the abstract.

2.8 Reporting guidelines

The relevant EQUATOR Network reporting guidelines should be followed depending on the type of study. For example, all randomized controlled trials submitted for publication should include a completed CONSORT flow chart as a cited figure and the completed CONSORT checklist should be uploaded with your submission as a supplementary file. Systematic reviews and meta-analyses should include the completed PRISMA flow chart as a cited figure and the completed PRISMA checklist should be uploaded with your submission as a supplementary file. The EQUATOR wizard can help you identify the appropriate guideline.

Other resources can be found at NLM’s Research Reporting Guidelines and Initiatives

The Editors of SRI recommend authors follow the below figure from The IDEAL Framework for Evaluating Surgical Innovation by Dimick et al.

……

更多详情:

https://journals.sagepub.com/author-instructions/SRI


  • 万维QQ投稿交流群    招募志愿者

    版权所有 Copyright@2009-2015豫ICP证合字09037080号

     纯自助论文投稿平台    E-mail:eshukan@163.com


投稿问答最小化  关闭